Oncology & Cancer

Researchers discover a key regulator of colon cancer

A team headed by Angel R. Nebreda at the Institute for Research in Biomedicine (IRB) identifies a dual role of the p38 protein in colon cancer. The study demonstrates that, on the one hand, p38 is important for the optimal ...

Oncology & Cancer

New approach makes cancer cells explode

Researchers at Karolinska Institutet in Sweden have discovered that a substance called Vacquinol-1 makes cells from glioblastoma, the most aggressive type of brain tumour, literally explode. When mice were given the substance, ...

Oncology & Cancer

Computer model simulates cancer growth and treatment at nano scale

(Medical Xpress)—A University of Adelaide PhD student has developed a computer model for simulating cancer tumour growth and treatment which is attracting interest from around the world as a first-line assessment of potential ...

Oncology & Cancer

Stopping tumors in their path

Glioblastoma (GBM) is the most common and deadly form of primary malignant brain cancer accounting for approximately 15% of all brain tumours and occurring mostly in adults between the ages of 45 and 70. The aggressive recurrent ...

Oncology & Cancer

Scientists uncover potential drug target to nip cancer in the bud

Scientists at A*STAR have discovered an enzyme, Wip1 phosphatase, as a potential target to weed out the progression of cancer. Although studies in the past have revealed that this enzyme plays a critical role in regulating ...

Oncology & Cancer

Redirecting our immune cells to help fight children's cancer

Immune cells, known as Natural Killer T cells, could be redirected to help fight the childhood cancer, neuroblastoma, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool ...

page 12 from 15